Natrox: Valuation, Funding & Investors

According to a recent LinkedIn post from Natrox, diabetes can affect foot health and daily care beyond blood-sugar management. The post emphasizes timely assessment and appropriate treatment when diabetic foot

According to a recent LinkedIn post from Natrox, NATROX® O₂ is designed to deliver a continuous flow of oxygen directly to the wound bed through a wearable treatment option. The

According to a recent LinkedIn post from Natrox, the company is highlighting a clinical case involving a chronic diabetic and Charcot foot wound. The post describes a 53-year-old male patient

According to a recent LinkedIn post from Natrox, the company participated in DFSICON 2026 in Bengaluru, India, engaging with healthcare professionals at the GRH booth to discuss chronic wound management.

According to a recent LinkedIn post from Natrox, the U.S. Durable Medical Equipment Medicare Administrative Contractors (DME MACs) have issued a proposed Local Coverage Determination, DL33797, for topical oxygen therapy

According to a recent LinkedIn post from Natrox, the company is emphasizing patient-centered approaches in wound care, focusing on shared decision-making between clinicians and patients. The post highlights that effective

According to a recent LinkedIn post from OneDosh, the company is presenting a panel with BGR at OneDosh Frontier ’26, an event focused on building cross-border payment infrastructure for Africa.

According to a recent LinkedIn post from ONA Therapeutics, Co-Founder and CEO Valerie Vanhooren and CMO Aleix Prat plan to attend investor and life-sciences events in London from November 15–19.

According to a recent LinkedIn post from Tomorro, the legal technology company is preparing to attend Les Rendez-vous des Transformations du Droit on November 24 and 25 at Paris’s Cité

According to a recent LinkedIn post from Artificial Labs, the company is examining what brokers mean when they discuss digitising a “mud map” during a market placement. The post distinguishes